Navigation Links
4,000 e-Books now available on ScienceDirect
Date:9/10/2007

Amsterdam, 10 September 2007 Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced the availability of more than 4,000 eBooks on ScienceDirect. eBooks on ScienceDirect comprise high-quality selected titles published from 1995 to the present. These include scientific and technical books spanning 18 subject areas, as well as books from renowned imprints including Pergamon and Academic Press. The launch is a major expansion to the reference works, handbooks and book series already available on ScienceDirect.

The eBooks on ScienceDirect program will, for the first time, make virtually all of Elseviers Science and Technology academic publication catalogue of books fully searchable. eBooks will be linked not only with other referenced book series, handbooks and reference works, but also the worlds largest repository of full-text journal content. This development offers researchers a significantly broader perspective of their field of study, from a single industry leading interface.

eBooks on ScienceDirect allows researchers to search and retrieve all relevant information published in books and journals on one easy-to-use platform, ensuring results in a broad range of information within various trusted sources, said Joep Verheggen, Director, ScienceDirect, Acquiring eBooks on ScienceDirect enables librarians to use their institutions budgets wisely and to best serve users by providing simultaneous access and quality information in a credible, familiar environment.

The launch of eBooks reflects ScienceDirects ongoing commitment to developing new content for users. eBooks will be included within the existing ScienceDirect platform, eliminating the need for users to learn a new interface. The 2,000 Book Series and Handbooks volumes and more than 55 titles of reference works already on ScienceDirect will be linked to eBooks and the Cited By feature. This will allow users to cross-reference cit
'/>"/>

Contact: Lauren Hillman
lauren.hillman@fusionpr.com
202-898-2000
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. A step toward the $1,000 personal genome using readily available lab equipment
2. Techniques available to detect soil that inhibits destructive soybean pest
3. Interactive 3-D atlas of mouse brain now available on web
4. Study suggests that publicly available genome data may contain small but significant errors
5. Scientists discover that widely available drug also helps fight kidney disease
6. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
7. Scientists discover new, readily available source of stem cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... N.Y., Oct. 21 What,s the cost of ... accidental death resulting from prescription medi...ood intentions, however, may be unaware that the l...ir teens from the ticking timebomb of prescription...n premium-quality medical supplies, has formed an ...
(Date:11/4/2009)...N.J., Oct. 26 BIO-key In...ader in finger-based biometric identification soft...tions at the AABB TXPO conference being held at th... 2009. BIO-key will provide hands-on product demon...echnology in booth #424. Also, at 5 PM on Monday, ...
(Date:11/4/2009)...PEL HILL Scientists at the University of North Ca...niversity of California, San Francisco have develo...ct new target diseases for existing drugs. , The... compares how similar the structures of all known ...ers -- known as ligands -- of disease targets with...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Study points to new uses, unexpected side effects of already existing drugs 2EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 1EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 2EFT BioTech Holdings Inc s Sea Vessel Completes Inaugural Passenger Voyage Across the Taiwan Strait 12850 3Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 1Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 2Cosmetic surgery appeals to men women with appearance based rejection sensitivity 50413 1Cosmetic surgery appeals to men women with appearance based rejection sensitivity 50413 2
...ancer survivors might one day avoid the prospect o...nstead for an approach that would involve using st...rsity of Pittsburgh researchers who are studying t... new breast tissue. , In animal models, the resea...ved stem cells that are seeded onto microscopic sc...
...s of increased plant respiration in response to hi...d as they have not taken into account plants, abil... researchers from Oak Ridge National Laboratory. ,...ence, a team led by Tony King cites ORNL findings ...e stored in plants and soil with the acclimation o...
...g gene first identified in a cabbage-eating moth m...ative to viruses for gene therapy, researchers say...-characterized jumping genes, or transposons, to i...esired change, such as making the cell resistant t...e piggyBac transposon was five to 10 times better ...
Other Biology News:Fat stem cells being studied as option for breast reconstruction 2Plants' role in global warming re-examined 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3
(Date:11/6/2009)...re-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced updated results from a Phase II study o...s metastatic to the lung in a poster presentation ...ety Meeting held in Miami Beach, Florida, from Nov...d "A Phase II Study of Intravenous REOLYSIN (Wild-...
(Date:11/5/2009)... The endangered black-footed ferre...This rare carnivore feeds on prairie dogs. The p...en entire population die-offs in towns occur. The...ented a ferret breeding program and has been relea...native habitat. Unfortunately, plague can sweep t...
(Date:11/5/2009)...wswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulle... for the quarter ended September 30, 2009. The Com...es that follow. ,, Third Quarter 2009 ,, T...1 per share for the third quarter of 2009 as compa...or the third quarter of 2008. ,, Net sales wer...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc....f state-of-the-art genetic analysis systems, today...d the company,s Scientific Advisory Board. His ca...zing novel molecular diagnostics for cancer detect... of computational biology systems for several biot...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...Conn. The State of Connecticut,s highest honor fo...gy, was presented this year to Yale Professor Tso...nductors. , The Connecticut Medal of Technology...ducation and the Connecticut Academy of Science a...th the Connecticut Medal of Science and is designe...
...10 Cardium Therapeutics,(Amex: CXM ) today repor...,quarter ended September 30, 2008, and outlined re...units: (1) InnerCool Therapies, (2) Tissue Repair,...http://www.newscom.com/cgi-bin/prnh/20051018/CARDI...es, Inc. The Company recently announced 510(k) cl...
... constant currency revenue growth of 12.9 percent,...rcent, constant currency), and improving profita... - Management reaffirms annual financial guidance... Hill-Rom Holdings,Inc. (NYSE: HRC ), announced u...uarter ended September 30, 2008 -- the second quar...
Other Biology Technology:Yale professor T.P. Ma awarded the Connecticut Medal of Technology 2Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 2Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 3Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 4Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 5Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 6Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 7Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 8Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 9Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 10Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units 11Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 2Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 3Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 4Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 5Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 6Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 7Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 8Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 9Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 10Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 11Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 12Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 13Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 14Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 15Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 16Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 17Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 18Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year 19
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Rat Anti-Mouse Macrophages, Metallophilic Monoclonal Antibody, Unconjugated from AbD Serotec
BMP-2 ELISA Kit from R&D Systems
Argarase from BioVision
Biology Products: